Literature DB >> 23696166

Evaluation and management of acquired methemoglobinemia associated with topical benzocaine use.

Mohammed Taleb1, Zubair Ashraf, Shahul Valavoor, Jodi Tinkel.   

Abstract

Benzocaine is a widely used topical oropharyngeal anesthetic and has been reported to cause methemoglobinemia. We discuss benzocaine-induced methemoglobinemia and review the causes, presentation, and management of this serious complication. Treatment with methylene blue will result in reversal of methemoglobinemia and clinical recovery in most cases but needs to be used at appropriate doses in carefully selected individuals. Physicians who perform procedures involving the application of benzocaine for topical anesthesia need to rapidly identify and treat methemoglobinemia to avoid significant associated morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23696166     DOI: 10.1007/s40256-013-0027-2

Source DB:  PubMed          Journal:  Am J Cardiovasc Drugs        ISSN: 1175-3277            Impact factor:   3.571


  4 in total

1.  Pediatric Exposures to Topical Benzocaine Preparations Reported to a Statewide Poison Control System.

Authors:  Rais Vohra; Serena Huntington; Jennifer Koike; Kevin Le; Richard J Geller
Journal:  West J Emerg Med       Date:  2017-07-14

2.  Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities.

Authors:  Sean M Hacking
Journal:  Med Hypotheses       Date:  2020-09-02       Impact factor: 1.538

3.  Determination of Benzocaine in Pharmaceutical Formulations by Indirect SERRS Assay Combined with Azo Coupling.

Authors:  Chao-Yang Zhao; Huimin Sui; Endi Xue; Li Li; Jie Zhang; Tao Xu; Xin Liang; Ying Yang
Journal:  Molecules       Date:  2022-07-14       Impact factor: 4.927

4.  A 32-Year-Old Female with AIDS, Pneumocystis jiroveci Pneumonia, and Methemoglobinemia.

Authors:  Guillermo J Giangreco; Dean Campbell; Mark J Cowan
Journal:  Case Rep Crit Care       Date:  2013-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.